INSTITUTION'S PROFILE
Servier Forschung und Pharma, Munich, Germany.
Publications (1)
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries.
Journal: The lancet. Psychiatry
Publication date: 2022
Journal: The lancet. Psychiatry
Publication Year: 2022